Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3′ noncoding region can elicit immunity in swine

Journal of Virology

Volumn 83, Issue 8, 2009, Pages 3475-3485

  Pulido, Miguel Rodríguez ^a,b   Sobrino, Francisco ^a,b   Borrego, Belén ^b   Sáiz, Margarita ^a,b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; NEUTRALIZING ANTIBODY; RNA VACCINE; VIRUS RNA; LIVE VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE DELETION; GENETIC TRANSFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; INOCULATION; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SYNTHESIS; SERUM; SWINE; VIROGENESIS; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS TRANSCRIPTION; 3' UNTRANSLATED REGION; ANIMAL; BLOOD; GENETICS; IMMUNIZATION; IMMUNOLOGY; LYMPHOCYTE; PATHOGENICITY; PHYSIOLOGY; SERODIAGNOSIS; SWINE DISEASE;

FOOT-AND-MOUTH DISEASE VIRUS; SUIDAE;

3' UNTRANSLATED REGIONS; ANIMALS; ANTIBODIES, VIRAL; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNIZATION, SECONDARY; LYMPHOCYTES; NEUTRALIZATION TESTS; RNA, VIRAL; SEQUENCE DELETION; SWINE; SWINE DISEASES; VACCINES, ATTENUATED; VIRAL VACCINES; VIRUS REPLICATION;

EID: 64049103834     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01836-08     Document Type: Article

References (64)

1. Aberle, J. H., S. W. Aberle, R. M. Kofler, and C. W. Mandl. 2005. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus. J. Virol. 79:15107-15113. (Pubitemid 43032293)
2. Alexandersen, S., M. Quan, C. Murphy, J. Knight, and Z. Zhang. 2003. Studies of quantitative parameters of virus excretion and transmission in pigs and cattle experimentally infected with foot-and-mouth disease virus. J. Comp. Pathol. 129:268-282. (Pubitemid 37321492)
3. Almeida, M. R., E. Rieder, J. Chinsangaram, G. Ward, C. Beard, M. J. Grubman, and P. W. Mason. 1998. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Virus Res. 55:49-60.
4. Baranowski, E., N. Molina, J. I. Núñez, F. Sobrino, and M. Sáiz. 2003. Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA. J. Virol. 77:11290-11295. (Pubitemid 37204320)
5. Baranowski, E., N. Sevilla, N. Verdaguer, C. M. Ruiz-Jarabo, E. Beck, and E. Domingo. 1998. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J. Virol. 72:6362-6372. (Pubitemid 28323947)
6. Beard, C., G. Ward, E. Rieder, J. Chinsangaram, M. J. Grubman, and P. W. Mason. 1999. Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J. Biotechnol. 73:243-249.
7. Belsham, G. J., and E. Martínez-Salas. 2004. Genome organisation, translation and replication of FMDV RNA, p. 19-52. In F. Sobrino and E. Domingo (ed.), Foot-and-mouth disease: current perspectives. Horizon Bioscience, Norfolk, United Kingdom.
8. Benvenisti, L., A. Rogel, L. Kuznetzova, S. Bujanover, Y. Becker, and Y. Stram. 2001. Gene gun-mediate DNA vaccination against foot-and-mouth disease virus. Vaccine 19:3885-3895.
9. Blanco, E., L. J. Romero, M. El Harrach, and J. M. Sánchez- Vizcaíno. 2002. Serological evidence of FMD subclinical infection in sheep population during the 1999 epidemic in Morocco. Vet. Microbiol. 85:13-21. (Pubitemid 34127648)
10. Blaney, J. E., Jr., A. P. Durbin, B. R. Murphy, and S. S. Whitehead. 2006. Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunol. 19:10-32.
11. Brown, D. M., C. T. Cornell, G. P. Tran, J. H. Nguyen, and B. L. Semler. 2005. An authentic 3′ noncoding region is necessary for efficient poliovirus replication. J. Virol. 79:11962-11973.
12. Bullido, R., N. Doménech, B. Alvarez, F. Alonso, M. Babín, A. Ezquerra, E. Ortuño, and J. Domínguez. 1997. Characterization of five monoclonal antibodies specific for swine class II major histocompatibility antigens and cross-reactivity studies with leukocytes of domestic animals. Dev. Comp. Immunol. 21:311-322. (Pubitemid 27329120)
13. Bullido, R., A. Ezquerra, F. Alonso, M. Gómez del Moral, and J. Domínguez. 1996. Characterization of a new monoclonal antibody (4B7) specific for porcine MHC (SLA) class I antigens. Investig. Agrar. Prod. Sanid. Anim. 11:29-37.
14. Carrillo, C., E. R. Tulman, G. Delhon, Z. Lu, A. Carreno, A. Vagnozzi, G. F. Kutish, and D. L. Rock. 2005. Comparative genomics of foot-and-mouth disease virus. J. Virol. 79:6487-6504. (Pubitemid 40617252)
15. Cedillo-Barron, L., M. Foster-Cuevas, G. J. Belsham, F. Lefevre, and R. M. Parkhouse. 2001. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J. Gen. Virol. 82:1713-1724. (Pubitemid 32611513)
16. Chinsangaram, J., P. W. Mason, and M. J. Grubman. 1998. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 16:1516-1522.
17. Collen, T. 1994. Foot-and-mouth disease (aphtovirus): viral T cell epitopes. In B. M. L. Goddeevis and I. Morrison (ed.), Cell mediated immunity in ruminants. CRC Press Inc., Boca Raton, FL.
18. Cubillos, C., B. G. de la Torre, A. Jakab, G. Clementi, E. Borras, J. Barcena, D. Andreu, F. Sobrino, and E. Blanco. 2008. Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J. Virol. 82:7223-7230.
19. Dobrikova, E., P. Florez, S. Bradrick, and M. Gromeier. 2003. Activity of a type 1 picornavirus internal ribosomal entry site is determined by sequences within the 3′ nontranslated region. Proc. Natl. Acad. Sci. USA 100:15125-15130. (Pubitemid 37518027)
20. Donaldson, A. 2004. Clinical signs of foot-and-mouth disease, p. 93-102. In F. Sobrino and E. Domingo (ed.), Foot-and-mouth disease: current perspectives. Horizon Bioscience, Norfolk, United Kingdom.
21. Durbin, A. P., R. A. Karron, W. Sun, D. W. Vaughn, M. J. Reynolds, J. R. Perreault, B. Thumar, R. Men, C. J. Lai, W. R. Elkins, R. M. Chanock, B. R. Murphy, and S. S. Whitehead. 2001. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region. Am. J. Trop. Med. Hyg. 65:405-413. (Pubitemid 33134570)
22. Eblé, P. L., A. Bouma, K. Weerdmeester, J. A. Stegeman, and A. Dekker. 2007. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs. Vaccine 25:1043-1054.
23. Escarmís, C., M. Toja, M. Medina, and E. Domingo. 1992. Modifications of the 5′ untranslated region of foot-and-mouth disease virus after prolonged persistence in cell culture. Virus Res. 26:113-125.
24. Ferris, N. P., D. P. King, S. M. Reid, G. H. Hutchings, A. E. Shaw, D. J. Paton, N. Goris, B. Haas, B. Hoffmann, E. Brocchi, M. Bugnetti, A. Dekker, and K. De Clercq. 2006. Foot-and-mouth disease virus: a first inter-laboratory comparison trial to evaluate virus isolation and RT-PCR detection methods. Vet. Microbiol. 117:130-140.
25. Fowler, V. L., D. J. Paton, E. Rieder, and P. V. Barnett. 2008. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle. Vaccine 26:1982-1989.
26. Francis, M. J., and L. Black. 1983. Antibody response in pig nasal fluid and serum following foot-and-mouth disease infection or vaccination. J. Hyg. (London) 91:329-334. (Pubitemid 14206541)
27. Ganges, L., M. Barrera, J. I. Núñez, I. Blanco, M. T. Frías, F. Rodríguez, and F. Sobrino. 2005. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. Vaccine 23:3741-3752.
28. García-Briones, M. M., E. Blanco, C. Chiva, D. Andreu, V. Ley, and F. Sobrino. 2004. Immunogenicity and T cell recognition in swine of foot-andmouth disease virus polymerase 3D. Virology 322:264-275.
29. Herrera, M., A. Grande-Pérez, C. Perales, and E. Domingo. 2008. Persistence of foot-and-mouth disease virus in cell culture revisited: implications for contingency in evolution. J. Gen. Virol. 89:232-244.
30. Hunziker, I. P., S. Harkins, R. Feuer, C. T. Cornell, and J. L. Whitton. 2004. Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge. Virology 330:196-208.
31. Jensen, M. J., and D. M. Moore. 1993. Phenotypic and functional characterization of mouse attenuated and virulent variants of foot-and-mouth disease virus type O1 Campos. Virology 193:604-613.
32. Kitching, R. P. 2005. Global epidemiology and prospects for control of foot-and-mouth disease. Curr. Top. Microbiol. Immunol. 288:133-148. (Pubitemid 39657081)
33. Kofler, R. M., J. H. Aberle, S. W. Aberle, S. L. Allison, F. X. Heinz, and C. W. Mandl. 2004. Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc. Natl. Acad. Sci. USA 101:1951-1956.
34. Leitner, W. W., L. N. Hwang, M. J. deVeer, A. Zhou, R. H. Silverman, B. R. Williams, T. W. Dubensky, H. Ying, and N. P. Restifo. 2003. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat. Med. 9:33-39.
35. Lewis, S. A., D. O. Morgan, and M. J. Grubman. 1991. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J. Virol. 65:6572-6580.
36. López de Quinto, S., M. Sáiz, D. de la Morena, F. Sobrino, and E. Martínez-Salas. 2002. IRES-driven translation is stimulated separately by the FMDV 3′-NCR and poly(A) sequences. Nucleic Acids Res. 30:4398-4405. (Pubitemid 35277250)
37. Martínez-Salas, E., and O. Fernández-Miragall. 2004. Picornavirus IRES: structure function relationship. Curr. Pharm. Des. 10:3757-3767.
38. Mason, P. W., S. V. Bezborodova, and T. M. Henry. 2002. Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J. Virol. 76:9686-9694.
39. Mateu, M. G., E. Rocha, O. Vicente, F. Vayreda, C. Navalpotro, D. Andreu, E. Pedroso, E. Giralt, L. Enjuanes, and E. Domingo. 1987. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Res. 8:261-274.
40. McCullough, K. C., and F. Sobrino. 2004. Immunology of foot-and-mouth disease, p. 173-222. In F. Sobrino and E. Domingo (ed.), Foot-and-mouth disease: current perspectives. Horizon Bioscience, Norfolk, United Kingdom.
41. McKenna, T. S., J. Lubroth, E. Rieder, B. Baxt, and P. W. Mason. 1995. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J. Virol. 69:5787-5790.
42. Melchers, W. J., J. G. Hoenderop, H. J. Bruins Slot, C. W. Pleij, E. V. Pilipenko, V. I. Agol, and J. M. Galama. 1997. Kissing of the two predominant hairpin loops in the coxsackie B virus 3′ untranslated region is the essential structural feature of the origin of replication required for negative-strand RNA synthesis. J. Virol. 71:686-696.
43. Merkle, I., M. J. van Ooij, F. J. van Kuppeveld, D. H. Glaudemans, J. M. Galama, A. Henke, R. Zell, and W. J. Melchers. 2002. Biological significance of a human enterovirus B-specific RNA element in the 3′ nontranslated region. J. Virol. 76:9900-9909.
44. Pacheco, J. M., M. C. Brum, M. P. Moraes, W. T. Golde, and M. J. Grubman. 2005. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337:205-209.
45. Pilipenko, E. V., S. V. Maslova, A. N. Sinyakov, and V. I. Agol. 1992. Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures. Nucleic Acids Res. 20:1739-1745.
46. Pilipenko, E. V., K. V. Poperechny, S. V. Maslova, W. J. Melchers, H. J. Slot, and V. I. Agol. 1996. Cis-element, oriR, involved in the initiation of (-) strand poliovirus RNA: a quasi-globular multi-domain RNA structure maintained by tertiary ('kissing') interactions. EMBO J. 15:5428-5436.
47. Pugachev, K. V., F. Guirakhoo, D. W. Trent, and T. P. Monath. 2003. Traditional and novel approaches to flavivirus vaccines. Int. J. Parasitol. 33:567-582. (Pubitemid 36638538)
48. Rodríguez Pulido, M., P. Serrano, M. Sáiz, and E. Martínez-Salas. 2007. Foot-and-mouth disease virus infection induces proteolytic cleavage of PTB, eIF3a,b, and PABP RNA-binding proteins. Virology 364:466-474.
49. Sa-Carvalho, D., E. Rieder, B. Baxt, R. Rodarte, A. Tanuri, and P. W. Mason. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71:5115-5123. (Pubitemid 27258183)
50. Sáiz, J. C., A. Rodríguez, M. González, F. Alonso, and F. Sobrino. 1992. Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J. Gen. Virol. 73:2601-2607.
51. Sáiz, M., D. B. De La Morena, E. Blanco, J. I. Núñez, R. Fernández, and J. M. Sánchez-Vizcaíno. 2003. Detection of foot-and-mouth disease virus from culture and clinical samples by reverse transcription-PCR coupled to restriction enzyme and sequence analysis. Vet. Res. 34:105-117. (Pubitemid 36240375)
52. Sáiz, M., S. Gómez, E. Martínez-Salas, and F. Sobrino. 2001. Deletion or substitution of the aphthovirus 3′ NCR abrogates infectivity and virus replication. J. Gen. Virol. 82:93-101.
53. Sáiz, M., J. I. Núñez, M. A. Jiménez-Clavero, E. Baranowski, and F. Sobrino. 2002. Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect. 4:1183-1192.
54. Sanz-Parra, A., M. A. Jiménez-Clavero, M. M. García- Briones, E. Blanco, F. Sobrino, and V. Ley. 1999. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology 259:129-134.
55. Serrano, P., M. Rodríguez Pulido, M. Sáiz, and E. Martínez-Salas. 2006. The 3′ end of the foot-and-mouth disease virus genome establishes two distinct long-range RNA-RNA interactions with the 5′ end region. J. Gen. Virol. 87:3013-3022.
56. Sobrino, F., M. Sáiz, M. A. Jiménez-Clavero, J. I. Núñez, M. F. Rosas, E. Baranowski, and V. Ley. 2001. Foot-and-mouth disease virus: a long known virus, but a current threat. Vet. Res. 32:1-30.
57. Taboga, O., C. Tami, E. Carrillo, J. I. Núñez, A. Rodríguez, J. C. Sáiz, E. Blanco, M. L. Valero, X. Roig, J. A. Camarero, D. Andreu, M. G. Mateu, E. Giralt, E. Domingo, F. Sobrino, and E. L. Palma. 1997. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71:2606-2614.
58. Todd, S., J. S. Towner, D. M. Brown, and B. L. Semler. 1997. Replication-competent picornaviruses with complete genomic RNA 3′ noncoding region deletions. J. Virol. 71:8868-8874.
59. van Ooij, M. J., C. Polacek, D. H. Glaudemans, J. Kuijpers, F. J. van Kuppeveld, R. Andino, V. I. Agol, and W. J. Melchers. 2006. Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element. Nucleic Acids Res. 34:2953-2965. (Pubitemid 44540423)
60. Vassilev, V. B., L. H. Gil, and R. O. Donis. 2001. Microparticle-mediated RNA immunization against bovine viral diarrhea virus. Vaccine 19:2012-2019.
61. Wang, C. Y., T. Y. Chang, A. M. Walfield, J. Ye, M. Shen, S. P. Chen, M. C. Li, Y. L. Lin, M. H. Jong, P. C. Yang, N. Chyr, E. Kramer, and F. Brown. 2002. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20:2603-2610.
62. Witwer, C., S. Rauscher, I. L. Hofacker, and P. F. Stadler. 2001. Conserved RNA secondary structures in Picornaviridae genomes. Nucleic Acids Res. 29:5079-5089. (Pubitemid 34065425)
63. Zheng, M., N. Jin, H. Zhang, M. Jin, H. Lu, M. Ma, C. Li, G. Yin, R. Wang, and Q. Liu. 2006. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus. J. Virol. Methods 136:230-237. (Pubitemid 44051598)
64. Zoll, J., H. A. Heus, F. J. van Kuppeveld, and W. J. Melchers. 2009. The structure-function relationship of the enterovirus 3′-UTR. Virus Res. 139:209-216.